The Significance of Exosomes in the Development and Treatment of Hepatocellular Carcinoma

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2020 Jan 6

PMID 31901224

Citations 122

Authors

Xin Li

Chuanyun Li

Liping Zhang

Min Wu

Ke Cao

Feifei Jiang

Dexi Chen

Ning Li

Weihua Li

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is the most commonmalignancy. Exsome plays a significant role in the elucidation of signal transduction pathways between hepatoma cells, angiogenesis and early diagnosis of HCC. Exosomes are small vesicular structures that mediate interaction between different types of cells, and contain a variety of components (including DNA, RNA, and proteins). Numerous studies have shown that these substances in exosomes are involved in growth, metastasis and angiogenesis in liver cancer, and then inhibited the growth of liver cancer by blocking the signaling pathway of liver cancer cells. In addition, the exosomal substances could also be used as markers for screening early liver cancer. In this review, we summarized to reveal the significance of exosomes in the occurrence, development, diagnosis and treatment of HCC, which in turn might help us to further elucidate the mechanism of exosomes in HCC, and promote the use of exosomes in the clinical diagnosis and treatment of HCC.

Citing Articles

MicroRNA-124a/Sirtuin 1 pathway inhibits autophagy to promote hepatocyte apoptosis in acute-on-chronic liver failure.

Xu H, Wang X, Wang Y, Shen C, Ma L, Zhao C Mol Biol Rep. 2025; 52(1):314.

PMID: 40088364 DOI: 10.1007/s11033-025-10373-x.

The RNA-binding protein ELAVL1 promotes Beclin1-mediated cellular autophagy and thus endometrial cancer development by affecting LncRNA-neat stability.

Luo Y, Zhong X, Sun X, Fan J Cancer Biol Ther. 2025; 26(1):2469927.

PMID: 40018990 PMC: 11875488. DOI: 10.1080/15384047.2025.2469927.

Optical sorting: past, present and future.

Yang M, Shi Y, Song Q, Wei Z, Dun X, Wang Z Light Sci Appl. 2025; 14(1):103.

PMID: 40011460 PMC: 11865320. DOI: 10.1038/s41377-024-01734-5.

Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges.

Sheikhi K, Ghaderi S, Firouzi H, Rahimibarghani S, Shabani E, Afkhami H Front Cell Dev Biol. 2025; 13:1517369.

PMID: 39963155 PMC: 11830822. DOI: 10.3389/fcell.2025.1517369.

PD1 Treg cell remodeling promotes immune homeostasis within peripheral blood and tumor microenvironment after microparticles-transarterial chemoembolization in hepatocellular carcinoma.

Ren Z, Wang Y, Jiang D, Liu Y, Yang X, Wang T Cancer Immunol Immunother. 2025; 74(3):109.

PMID: 39937280 PMC: 11822157. DOI: 10.1007/s00262-025-03962-z.

References

Crispe I . The liver as a lymphoid organ. Annu Rev Immunol. 2009; 27:147-63. DOI: 10.1146/annurev.immunol.021908.132629. View

El-Serag H, Rudolph K . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-76. DOI: 10.1053/j.gastro.2007.04.061. View

Takahashi K, Yan I, Wood J, Haga H, Patel T . Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014; 12(10):1377-87. PMC: 4201956. DOI: 10.1158/1541-7786.MCR-13-0636. View

Vella L . The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol. 2015; 4:361. PMC: 4271613. DOI: 10.3389/fonc.2014.00361. View

Luga V, Zhang L, Viloria-Petit A, Ogunjimi A, Inanlou M, Chiu E . Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151(7):1542-56. DOI: 10.1016/j.cell.2012.11.024. View

Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-90. DOI: 10.1056/NEJMoa0708857. View

Chen R, Xu X, Tao Y, Qian Z, Yu Y . Exosomes in hepatocellular carcinoma: a new horizon. Cell Commun Signal. 2019; 17(1):1. PMC: 6323788. DOI: 10.1186/s12964-018-0315-1. View

Yu X, Odenthal M, Fries J . Exosomes as miRNA Carriers: Formation-Function-Future. Int J Mol Sci. 2016; 17(12). PMC: 5187828. DOI: 10.3390/ijms17122028. View

Ma X, Yuan T, Yang C, Wang Z, Zang Y, Wu L . X-inactive-specific transcript of peripheral blood cells is regulated by exosomal Jpx and acts as a biomarker for female patients with hepatocellular carcinoma. Ther Adv Med Oncol. 2018; 9(11):665-677. PMC: 5764152. DOI: 10.1177/1758834017731052. View

10.

Sugimachi K, Matsumura T, Hirata H, Uchi R, Ueda M, Ueo H . Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br J Cancer. 2015; 112(3):532-8. PMC: 4453648. DOI: 10.1038/bjc.2014.621. View

11.

Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y . HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018; 9(5):513. PMC: 5938707. DOI: 10.1038/s41419-018-0534-9. View

12.

Henne W, Buchkovich N, Emr S . The ESCRT pathway. Dev Cell. 2011; 21(1):77-91. DOI: 10.1016/j.devcel.2011.05.015. View

13.

Roma-Rodrigues C, Raposo L, Cabral R, Paradinha F, Baptista P, Fernandes A . Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy. Int J Mol Sci. 2017; 18(1). PMC: 5297795. DOI: 10.3390/ijms18010162. View

14.

Budnik V, Ruiz-Canada C, Wendler F . Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016; 17(3):160-72. PMC: 4989863. DOI: 10.1038/nrn.2015.29. View

15.

Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T . Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018; 175(5):1289-1306.e20. PMC: 6242467. DOI: 10.1016/j.cell.2018.09.053. View

16.

Thery C . Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011; 3:15. PMC: 3155154. DOI: 10.3410/B3-15. View

17.

Bowers K, Lottridge J, Helliwell S, Goldthwaite L, Luzio J, Stevens T . Protein-protein interactions of ESCRT complexes in the yeast Saccharomyces cerevisiae. Traffic. 2004; 5(3):194-210. DOI: 10.1111/j.1600-0854.2004.00169.x. View

18.

Andre F, Schartz N, Movassagh M, Flament C, Pautier P, Morice P . Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002; 360(9329):295-305. DOI: 10.1016/S0140-6736(02)09552-1. View

19.

Karaosmanoglu O, Banerjee S, Sivas H . Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Cell Oncol (Dordr). 2018; 41(4):439-453. DOI: 10.1007/s13402-018-0384-6. View

20.

Yoshida G, Azuma A, Miura Y, Orimo A . Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies. Int J Mol Sci. 2019; 20(9). PMC: 6539414. DOI: 10.3390/ijms20092256. View